Related Experiment Video
Updated: Jul 19, 2026

09:59
A Magnetic Resonance Imaging Protocol for Stroke Onset Time Estimation in Permanent Cerebral Ischemia
Published on: September 16, 2017
14.1K
Rapid Assay Diagnostic for Acute Stroke Recognition (RADAR): study protocol for a diagnostic accuracy study
Lisa Shaw1, David Burgess2, Anand Dixit3
1Stroke Research Group, Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK lisa.shaw@newcastle.ac.uk.
BMJ Open
|August 9, 2024
Summary
A new portable test accurately identifies large-vessel occlusion (LVO) stroke, potentially speeding up treatment. This diagnostic tool could help select patients for direct transfer to specialized thrombectomy centers, reducing critical delays.
Area of Science:
- Neurology
- Medical Diagnostics
- Biomarkers
Background:
- Large-vessel occlusion (LVO) stroke requires time-critical thrombectomy, often necessitating patient transfer to specialized centers.
- Current transfer protocols can lead to significant delays in treatment initiation.
- Accurate and rapid diagnostic tools are needed to streamline patient selection and transfer.
Purpose of the Study:
- To evaluate the diagnostic accuracy of a novel rapid portable test for identifying LVO stroke.
- To assess the potential of the test in selecting patients for direct admission to thrombectomy-capable centers.
Main Methods:
- Prospective observational cohort study (RADAR) in English stroke units.
- Index test: 'LVOne test' using fingerprick blood to detect d-dimer and glial fibrillary acidic protein.
- Reference standard: Adjudicated CT/MRI brain±CT/MR angiography to confirm stroke type and LVO.
Main Results:
- The study aims to determine sensitivity, specificity, and predictive values for LVO stroke detection.
- A primary analysis population of 276 participants is powered to detect a test specificity of 92% for LVO stroke.
- A total study population of 552 participants will allow evaluation in milder symptoms and unknown onset times.
Conclusions:
- The 'LVOne test' shows promise as a rapid, portable diagnostic tool for LVO stroke.
- Successful implementation could optimize patient pathways and reduce treatment delays.
- Further validation in broader populations will confirm its clinical utility.

